Avidity Biosciences Supports World Facioscapulohumeral Muscular Dystrophy (FSHD) Day and Presents Preclinical Data from FSHD Program

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

Related Keywords

San Diego ,California ,United States ,Florida ,Orlando ,Ukraine ,Kath Gallagher ,Cherise Adkins ,W Michael Flanagan ,Sarah Boyce ,Linkedin ,Twitter ,Company Contact ,Prnewswire Avidity Biosciences Inc ,Nasdaq ,Exchange Commission ,Society International Research Congress ,Avidity Biosciences Inc ,Oral Presentation ,Antibody Oligonucleotide Conjugates ,International Research Congress ,Oligonucleotide Conjugates ,Private Securities Litigation Reform Act ,Avidity Biosciences ,Nc ,